추천 제품
양식
powder
Quality Level
SMILES string
CC[C@@H]1CN2CCC1CC2[C@H](Oc3nnc(O[C@@H](C4CC5CCN4C[C@@H]5CC)c6ccnc7ccc(OC)cc67)c8ccccc38)c9ccnc%10ccc(OC)cc9%10
InChI
1S/C48H54N6O4/c1-5-29-27-53-21-17-31(29)23-43(53)45(35-15-19-49-41-13-11-33(55-3)25-39(35)41)57-47-37-9-7-8-10-38(37)48(52-51-47)58-46(44-24-32-18-22-54(44)28-30(32)6-2)36-16-20-50-42-14-12-34(56-4)26-40(36)42/h7-16,19-20,25-26,29-32,43-46H,5-6,17-18,21-24,27-28H2,1-4H3/t29-,30-,31-,32-,43+,44+,45-,46-/m0/s1
InChI key
YUCBLVFHJWOYDN-HVLQGHBFSA-N
일반 설명
Contains chiral ligand (DHQD)2PHAL
AD-mix-β is an oxidant used for the enantioselective synthesis of 2-Hydroxy-5-methyl-3-hexanone.
AD-mix-β is an oxidant used for the enantioselective synthesis of 2-Hydroxy-5-methyl-3-hexanone.
애플리케이션
Catalyst employed in the Sharpless Asymmetric Dihyroxylation of (E,E)- or (E,Z)-1,3-dienoates. Also used in the preparation of ß-hydroxy-γ-lactones from ß,γ-unsaturated esters.
Reagent for Sharpless Asymmetric Dihydroxylation.
성분
Mixture contains:
(DHQD)2PHAL (Cat. No. 392731) 0.0016 mole
Potassium carbonate, powder0.4988 mole
Potassium ferricyanide0.4988 mole
Potassium osmate dihydrate0.0007 mole
(DHQD)2PHAL (Cat. No. 392731) 0.0016 mole
Potassium carbonate, powder0.4988 mole
Potassium ferricyanide0.4988 mole
Potassium osmate dihydrate0.0007 mole
법적 정보
Sold under license from Rhodia Pharma Solutions.
신호어
Warning
유해 및 위험 성명서
Hazard Classifications
Aquatic Chronic 2 - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
표적 기관
Respiratory system
보충제 위험성
Storage Class Code
13 - Non Combustible Solids
WGK
WGK 2
Flash Point (°F)
Not applicable
Flash Point (°C)
Not applicable
개인 보호 장비
dust mask type N95 (US), Eyeshields, Gloves
이미 열람한 고객
(4R)-4-[(1R)-1, 2-Dihydroxyethyl]-1-[(1R)-1-phenylethyl] pyrrolidin-2-one.
Blaser A and Boyd PDW.
Acta Crystallographica Section E, Structure Reports Online, 64(9), o1851-o1851 (2008)
European Journal of Organic Chemistry, 2669-2669 (2006)
Chemical Reviews, 94, 2483-2483 (1994)
First asymmetric synthesis of CJ-14877 and its enantiomer and their interleukin-1? inhibitory activities.
Aoyagi Y, et al.
Bioorganic & Medicinal Chemistry Letters, 19(7), 1876-1878 (2009)
The Journal of Organic Chemistry, 57, 2768-2768 (1992)
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.